These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3059775)

  • 21. Antiarthritic effect of lonicerin on Candida albicans arthritis in mice.
    Lee JH; Han Y
    Arch Pharm Res; 2011 May; 34(5):853-9. PubMed ID: 21656372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Candida and AIDS: evidence for protective antibody.
    Matthews R; Burnie J; Smith D; Clark I; Midgley J; Conolly M; Gazzard B
    Lancet; 1988 Jul; 2(8605):263-6. PubMed ID: 2899245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Current state of immunology of visceral mycoses].
    Kashkin KP
    Vestn Dermatol Venerol; 1978 Nov; (11):38-43. PubMed ID: 366947
    [No Abstract]   [Full Text] [Related]  

  • 24. Modulation of macrophage phagocytic activity by cell wall components of Candida albicans.
    Szabo I; Guan L; Rogers TJ
    Cell Immunol; 1995 Sep; 164(2):182-8. PubMed ID: 7656326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cellular basis for opioid-induced immunosuppression.
    Guan L; Townsend R; Eisenstein TK; Adler MW; Rogers TJ
    Adv Exp Med Biol; 1995; 373():57-64. PubMed ID: 7668161
    [No Abstract]   [Full Text] [Related]  

  • 26. Candida albicans: cellular immune system interactions during different stages of the menstrual cycle.
    Kalo-Klein A; Witkin SS
    Am J Obstet Gynecol; 1989 Nov; 161(5):1132-6. PubMed ID: 2686440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of Candida albicans infection on the immunological response in mice].
    Jakoniuk P; Jablońska W; Borowski J
    Gruzlica; 1972; 40(12):1139-45. PubMed ID: 4567377
    [No Abstract]   [Full Text] [Related]  

  • 28. Protection against rat vaginal candidiasis by adoptive transfer of vaginal B lymphocytes.
    De Bernardis F; Santoni G; Boccanera M; Lucciarini R; Arancia S; Sandini S; Amantini C; Cassone A
    FEMS Yeast Res; 2010 Jun; 10(4):432-40. PubMed ID: 20402794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TLR-2, IL-10 and IL-17-mediated immunity in experimental chemotherapy murine model of systemic candidiasis; cyclophosphamides' impact and roles.
    Dehghan P; Tolouie S; Baradaran B; Nami S; Morovati H
    Microb Pathog; 2018 Jun; 119():183-192. PubMed ID: 29673975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induced resistance to Candida albicans in BALB/c mice during short-term immunosuppression with cyclophosphamide.
    van Wyk CW; van der Bijl P; Cooper RC
    Lab Anim Sci; 1995 Feb; 45(1):101-6. PubMed ID: 7752605
    [No Abstract]   [Full Text] [Related]  

  • 31. The cellular immunity in patients sensitized to Candida albicans and its corresponding humoral response.
    Oehling A; Crisci CD; Subirá ML; Jerez J
    Allergol Immunopathol (Madr); 1976; 4(5):333-44. PubMed ID: 795291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-mediated immune responses of mice in experimental Candida infection: the influence of canditoxin on activity of lymphoid cells [proceedings].
    Uchida K; Iwata K
    Jpn J Med Sci Biol; 1978 Apr; 31(2):195-7. PubMed ID: 355686
    [No Abstract]   [Full Text] [Related]  

  • 33. Stimulation of human B cells specific for Candida albicans for monoclonal antibody production.
    Davenport C; Bottazzo GF; Todd I
    FEMS Microbiol Immunol; 1992 Aug; 4(6):335-43. PubMed ID: 1326299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leukocyte inhibitory factor (LIF): production by purified human T and B lymphocytes.
    Chess L; Rocklin RE; MacDermott RP; David JR; Schlossman SF
    J Immunol; 1975 Jul; 115(1):315-7. PubMed ID: 50357
    [No Abstract]   [Full Text] [Related]  

  • 35. Phagocytic capacity of human leukocytes preincubated with Imuran and prednisone.
    Kotulová D; Stefanovic J
    J Hyg Epidemiol Microbiol Immunol; 1983; 27(3):253-7. PubMed ID: 6358349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defective killing of Candida albicans hyphae by neutrophils from beige mice.
    Jones-Carson J; Vazquez-Torres A; Balish E
    J Infect Dis; 1995 Jun; 171(6):1664-7. PubMed ID: 7769315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responses of T and B lymphocytes to a Paracoccidioides brasiliensis cell wall extract in healthy sensitized and nonsensitized subjects.
    Benard G; Durandy A; Assis CM; Hong MA; Orii NM; Sato MN; Mendes-Gianini MJ; Lacaz CS; Duarte AJ
    Am J Trop Med Hyg; 1995 Aug; 53(2):189-94. PubMed ID: 7677223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mildly oxidized low-density lipoprotein inhibits the in vitro induction of the specific antibody response to Candida albicans.
    Giordani L; Mattioli B; Quaranta MG; Giacomini E; Libri I; Varì R; Masella R; Viora M
    Free Radic Biol Med; 2005 Oct; 39(7):960-9. PubMed ID: 16140215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of human polymorphonuclear neutrophil (PMN) activity against Candida albicans by large granular lymphocytes via release of a PMN-activating factor.
    Djeu JY; Blanchard DK
    J Immunol; 1987 Oct; 139(8):2761-7. PubMed ID: 2443572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired immunity to systemic candidiasis in immunodeficient mice: role of antibody to heat-shock protein 90.
    Matthews R; Burnie J
    J Infect Dis; 1992 Nov; 166(5):1193-5. PubMed ID: 1402035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.